ClinicalTrials.gg
CompletedNCT07113899Updated Aug 11, 2025

HOPE AND ACCEPTANCE AT THE END OF LIFE - IMPACT OF SPIRITUALITY ON PALLIATIVE CARE PATIENTS

An interventional study of Approach to spirituality through hope and acceptance in Hope, Acceptance and Spirituality, sponsored by Unidade Local de Saúde de Coimbra, EPE. Completed at 1 site in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-11.

Sponsored by Unidade Local de Saúde de Coimbra, EPE · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jan 2025, registered Aug 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to evaluate the hope and acceptance among patients visited by the Equipa Comunitária de Suporte em Cuidados Paliativos do Baixo Mondego. This study is a prospective longitudinal research study. The sample consisted of two groups: the Intervention Group, which included patients from the network of the Equipa Comunitária de Suporte em Cuidados Paliativos do Baixo Mondego (ECSCP-BM), and the Control Group, with selected patients from Unidade de Saúde Familiar Nautilus e Unidade de Saúde Familiar Coimbra Centro, with serious illness, comorbidities, and a poor prognosis. The patients chosen from ECSCP-BM were made up only of new patients referred to the team without any prior home consultations. The first questionnaire application took place during the first visit, and the second one was administered fourteen days later. The Primary Health Care patients were selected by invitation, and the questionnaire was administered. It included sociodemographic data, clinical data, the Herth Hope Index - PT and open questions.

02

Conditions studied

  • Hope
  • Acceptance
  • Spirituality

Browse trials for

Keywords

  • hope
  • acceptance
  • spirituality
  • end of life
  • palliative care
03

In context

Death

456 studies on the registry are indexed under Death; 86 are open to participants now.

This study's enrollment of 20 is below the median of 163 across 210 interventional studies indexed under Death.

Browse Death studies →

Lead sponsor

Unidade Local de Saúde de Coimbra, EPE is the lead sponsor of 5 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • new referrals made by the family doctor to the community palliative care support team (which integrated the patient into the palliative care team network for the first time) - for the intervention group
  • patients registered at the Nautilus Family Health Unit or Coimbra Centro Family Health Unit with serious pathology, comorbidities and reserved prognosis - for the control group

Exclusion criteria

Exclusion Criteria:

  • age under 18
  • pregnancy
  • altered state of consciousness or dementia
  • low level of education
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    ECSCP

    Patients visited at home by the community palliative care support team

    Other: Approach to spirituality through hope and acceptance

  • No intervention
    CSP

    Patients with follow-up consultations by primary health care

Interventions

  • OtherApproach to spirituality through hope and acceptance

    This study is a prospective longitudinal research study. The sample consisted of two groups: the Intervention Group, which included patients from the community palliative care support team (ECSCP-BM), and the Control Group, with primary health care selected patients from the family health units Nautilus and Coimbra Centro (CSP), with serious illness, comorbidities, and a poor prognosis. The patients chosen from ECSCP-BM were made up only of new patients referred to the team without any prior home consultations. The first questionnaire application took place during the first visit, and the second one was administered fourteen days later. The Primary Health Care patients were selected by invitation, and the questionnaire was administered. It included sociodemographic data, clinical data, the Herth Hope Index and open questions. During the palliative care team's home visit, spirituality was addressed in in the clinical history through the assessment of hope and acceptance.

06

What researchers measure

Primary outcomes

  1. Hope

    Participants answered questions on the Hope Scale. There were 9 questions with 4 possible answers. Each answer was scored from 1 to 4. The maximum score on the scale was 36.

    Time frame: 5 months

  2. Acceptance

    Participants answered three open-ended questions to assess their acceptance. These questions were asked to the control group and at the first assessment of the intervention group. At the second assessment of the intervention group, after 14 days, a fourth question was also asked, assessing the team's intervention during those 14 days.

    Time frame: 5 months

07

Study locations

1 site
  • Lutenio Soares Faria Junior
    Coimbra, Coimbra District 3000-317, Portugal
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2025 to primary completion in May 2025, 4 months.

Of 106 non-industry interventional studies with no phase under Death, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 48. This study's 4 months is below that.

Counting every sponsor, half of 110 studies reached it within 24 months; a quarter within 14 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 3, 2025
First posted
Aug 11, 2025
StartActual
Jan 1, 2025
Primary completionActual
May 31, 2025
CompletionActual
May 31, 2025
Last update
Aug 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07113899
Lead sponsor
Unidade Local de Saúde de Coimbra, EPE
Responsible party
Lutenio Junior (Principal Investigator, Unidade Local de Saúde de Coimbra, EPE) — Principal investigator
First posted
Aug 11, 2025
Start date
Jan 1, 2025
Primary completion
May 31, 2025
Completion
May 31, 2025
Last update
Aug 11, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion